Back
Monopar Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
73
MNPR
Monopar Therapeutics
Last Price:
$37.03
Seasonality Move:
-15.23%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.
Monopar Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.68 | Sell |
| 20-day SMA: | 40.35 | Sell |
| 50-day SMA: | 37.36 | Sell |
| 200-day SMA: | 23.35 | Buy |
| 8-day EMA: | 37.87 | Sell |
| 20-day EMA: | 38.71 | Sell |
| 50-day EMA: | 37.76 | Sell |
| 200-day EMA: | 26.76 | Buy |
Monopar Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.29 | Sell |
| Relative Strength Index (14 RSI): | 46.85 | Sell |
| Chaikin Money Flow: | 2073 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.24 - 43.02) | Sell |
| Bollinger Bands (100): | (28.59 - 43.43) | Buy |
Monopar Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Monopar Therapeutics Stock
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 36.90 while MNPR 8-day simple moving average is 37.68, which is a Sell signal.
-
The stock price of MNPR is 36.90 while Monopar Therapeutics 20-day SMA is 40.35, which makes it a Sell.
-
Monopar Therapeutics 50-day simple moving average is 37.36 while MNPR share price is 36.90, making it a Sell technically.
-
MNPR stock price is 36.90 and Monopar Therapeutics 200-day simple moving average is 23.35, creating a Buy signal.
MNPR Technical Analysis vs Fundamental Analysis
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Is Monopar Therapeutics a Buy or a Sell?
-
Monopar Therapeutics stock is rated a BuyThe current Monopar Therapeutics [MNPR] share price is $36.90. The Score for MNPR is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
Monopar Therapeutics Stock Info
Market Cap:
225.7M
Price in USD:
36.90
Share Volume:
14.2K
Monopar Therapeutics 52-Week Range
52-Week High:
54.30
52-Week Low:
1.72
Buy
73
Monopar Therapeutics (MNPR)
is a Buy
Monopar Therapeutics Share Price Forecast
-
What is the Monopar Therapeutics stock price today?The Monopar Therapeutics stock price is 36.90 USD today.
-
Will MNPR stock go up or go down?Monopar Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Monopar Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Monopar Therapeutics is not overvalued.
Is Monopar Therapeutics Stock a Buy?
-
Monopar Therapeutics share price is 36.90 while MNPR 8-day exponential moving average is 37.87, which is a Sell signal.
-
The stock price of MNPR is 36.90 while Monopar Therapeutics 20-day EMA is 38.71, which makes it a Sell.
-
Monopar Therapeutics 50-day exponential moving average is 37.76 while MNPR share price is 36.90, making it a Sell technically.
-
MNPR stock price is 36.90 and Monopar Therapeutics 200-day simple moving average is 26.76, creating a Buy signal.
Fundamental Analysis of Monopar Therapeutics
Is Monopar Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.
Technical Analysis of Monopar Therapeutics
Should I short Monopar Therapeutics stock?
-
MNPR Moving Average Covergence Divergence (MACD) indicator is -0.29, suggesting Monopar Therapeutics is a Sell
-
Monopar Therapeutics Relative Strength Index (RSI) is 46.85, which suggest Monopar Therapeutics is oversold
-
The Bollinger Bands (25) for Monopar Therapeutics is (37.24 - 43.02), which suggest Monopar Therapeutics is a Buy
-
The Bollinger Bands (100) for Monopar Therapeutics is (28.59 - 43.43), which suggest Monopar Therapeutics is a Buy
* Monopar Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.